Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry.
Pawel E Buszman, Piotr P Buszman, R Stefan Kiesz...
https://pubmed.ncbi.nlm.nih.gov/19699048/Actively Recruiting
Led by American Heart of Poland · Updated on 2026-07-08
1000
Participants Needed
9
Research Sites
100 weeks
Total Duration
Researchers are investigating the best way to treat patients with multivessel coronary artery disease or left main narrowing who experience symptoms of acute ischemia, specifically those with non-ST-segment elevation acute coronary syndrome NSTE-ACS. This trial compares two treatments percutaneous coronary intervention PCI with drug-eluting stents and coronary artery bypass grafting CABG. The study aims to understand which method offers better outcomes for patients with complex coronary artery disease who need early invasive treatment. The study enrolls patients with multivessel disease or left main coronary artery disease, eligible for invasive treatment and with a Syntax Score below 33. Participants will be randomly assigned to receive either PCI, involving fractional flow reserve or iFR measurements and optimized stent implantation, or CABG surgery, performed with techniques including on-pump or off-pump methods. Treatment decisions involve a Heart Team consultation, and both approaches aim for complete revascularization. The trial will follow patients over time to compare outcomes. Participants will have follow-up visits including cardiac echocardiography and stress tests after hospitalization. The study will monitor major adverse cardiac and cerebral events MACCE, serious adverse events, procedural complications, cost effectiveness, and heart function over one year and beyond. Secondary outcomes include bleeding, atrial fibrillation, heart failure, rehospitalization, and quality of life. The total study duration extends until 2030, with primary outcome assessment at one year.
CONDITIONS
Revascularization Strategies in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) and Severe Coronary Artery Disease
N
Natalia Pydyn, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
American Heart of Poland
Lead Sponsor
Andrzej Frycz Modrzewski Krakow University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 1 year
Participants receive either PCI with drug-eluting stents or coronary artery bypass grafting (CABG) as assigned. Both procedures aim for complete revascularization based on clinical and anatomical assessments.
Four specialist follow-up visits with cardiac echo and stress tests
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Pawel E Buszman, Piotr P Buszman, R Stefan Kiesz...
https://pubmed.ncbi.nlm.nih.gov/19699048/Piotr P Buszman, Andrzej Bochenek, Magda Konkolewska...
https://pubmed.ncbi.nlm.nih.gov/19901409/Pawel E Buszman, Stefan R Kiesz, Andrzej Bochenek...
https://pubmed.ncbi.nlm.nih.gov/18237682/Duk-Woo Park, Young-Hak Kim, Sung-Cheol Yun...
https://pubmed.ncbi.nlm.nih.gov/20946993/Duk-Woo Park, Ki Bae Seung, Young-Hak Kim...
https://pubmed.ncbi.nlm.nih.gov/20451344/American Heart of Poland
Lead Sponsor
Andrzej Frycz Modrzewski Krakow University
Collaborating Sponsor